Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""20351327"" wg kryterium: Wszystkie pola


Tytuł :
Chemoradiation treatment patterns among United States Veteran Health Administration patients with unresectable stage III non-small cell lung cancer.
Autorzy :
Hung, Anna (AUTHOR)
Lee, Kyung Min (AUTHOR)
Lynch, Julie A. (AUTHOR)
Li, Yanhong (AUTHOR)
Poonnen, Pradeep (AUTHOR)
Efimova, Olga V. (AUTHOR)
Hintze, Bradley J. (AUTHOR)
Buckingham, Trudy (AUTHOR)
Yong, Candice (AUTHOR)
Seal, Brian (AUTHOR)
Kelley, Michael J. (AUTHOR)
Reed, Shelby D. (AUTHOR)
Pokaż więcej
Źródło :
BMC Cancer. 7/16/2021, Vol. 21 Issue 1, p1-11. 11p.
Czasopismo naukowe
Tytuł :
Predictors of chemoradiotherapy versus single modality therapy and overall survival among patients with unresectable, stage III non-small cell lung cancer.
Autorzy :
Bobbili, Priyanka (AUTHOR)
Ryan, Kellie (AUTHOR)
DerSarkissian, Maral (AUTHOR)
Dua, Akanksha (AUTHOR)
Yee, Christopher (AUTHOR)
Duh, Mei Sheng (AUTHOR)
Gomez, Jorge E. (AUTHOR)
Pokaż więcej
Źródło :
PLoS ONE. 3/18/2020, Vol. 15 Issue 3, p1-17. 17p.
Czasopismo naukowe
Tytuł :
Robust, independent and relevant prognostic F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?
Autorzy :
Konert, Tom (AUTHOR)
Everitt, Sarah (AUTHOR)
La Fontaine, Matthew D. (AUTHOR)
van de Kamer, Jeroen B. (AUTHOR)
MacManus, Michael P. (AUTHOR)
Vogel, Wouter V. (AUTHOR)
Callahan, Jason (AUTHOR)
Sonke, Jan-Jakob (AUTHOR)
Pokaż więcej
Źródło :
PLoS ONE. 2/25/2020, Vol. 15 Issue 2, p1-20. 20p.
Czasopismo naukowe
Tytuł :
Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach.
Autorzy :
Bruni, Alessio (AUTHOR)
Giaj-Levra, Niccolò (AUTHOR)
Ciammella, Patrizia (AUTHOR)
Maragna, Virginia (AUTHOR)
Ferrari, Katia (AUTHOR)
Bonti, Viola (AUTHOR)
Grossi, Francesco (AUTHOR)
Greco, Stefania (AUTHOR)
Greco, Carlo (AUTHOR)
Borghetti, Paolo (AUTHOR)
Franceschini, Davide (AUTHOR)
Capelletto, Enrica (AUTHOR)
Perna, Marco (AUTHOR)
Banna, Giuseppe (AUTHOR)
Vagge, Stefano (AUTHOR)
Baldini, Editta (AUTHOR)
Bria, Emilio (AUTHOR)
Botti, Andrea (AUTHOR)
Tiseo, Marcello (AUTHOR)
Paci, Massimiliano (AUTHOR)
Pokaż więcej
Źródło :
PLoS ONE. 11/13/2019, Vol. 14 Issue 11, p1-11. 11p.
Czasopismo naukowe
Tytuł :
Trends in radiotherapy inpatient admissions in Germany: a population-based study over a 10-year period.
Autorzy :
Medenwald D; Department of Radiation Oncology, University Hospital Halle (Saale), Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany. .
Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.
Klautke G; Department of Radiation Oncology, Chemnitz Hospital, Chemnitz, Germany.
Langer S; Department of Radiation Oncology, University Hospital Halle (Saale), Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany.
Würschmidt F; Radiological Alliance, Hamburg, Germany.
Vordermark D; Department of Radiation Oncology, University Hospital Halle (Saale), Ernst-Grube-Str. 40, 06120, Halle (Saale), Germany.
Pokaż więcej
Źródło :
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] [Strahlenther Onkol] 2021 Oct; Vol. 197 (10), pp. 865-875. Date of Electronic Publication: 2021 Sep 03.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost Effectiveness of Durvalumab in Unresectable Stage III NSCLC: 4-Year Survival Update and Model Validation from a UK Healthcare Perspective.
Autorzy :
Dunlop W; AstraZeneca Global Health Economics & Payer Evidence (Oncology), 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK. .
van Keep M; BresMed Netherlands, Utrecht, The Netherlands.
Elroy P; BresMed Netherlands, Utrecht, The Netherlands.
Perez ID; AstraZeneca, Gaithersburg, MD, USA.
Ouwens MJNM; AstraZeneca, Gothenburg, Sweden.
Sarbajna T; AstraZeneca Global Health Economics & Payer Evidence (Oncology), 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK.
Zhang Y; AstraZeneca, Gaithersburg, MD, USA.
Greystoke A; Northern Centre for Cancer Care, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Pokaż więcej
Źródło :
PharmacoEconomics - open [Pharmacoecon Open] 2021 Sep 16. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Treatment patterns and survival outcomes for patients with non-small cell lung cancer in the UK in the preimmunology era: a REAL-Oncology database analysis from the I-O Optimise initiative.
Autorzy :
Snee M; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK .
Cheeseman S; REAL Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Thompson M; REAL Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Riaz M; REAL Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Sopwith W; REAL Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Lacoin L; Epi-Fit, Bordeaux, Nouvelle-Aquitaine, UK.
Chaib C; Research & Development Medical Affairs, Bristol Myers Squibb, Madrid, Spain.
Daumont MJ; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Braine-l'Alleud, Belgium.
Penrod JR; Worldwide Health Economics & Outcomes Research, Bristol Myers Squibb, Princeton, New Jersey, USA.
Hall G; Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Leeds Institute for Data Analytics, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2021 Sep 15; Vol. 11 (9), pp. e046396. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Non-Small-Cell Lung*/pathology
Carcinoma, Non-Small-Cell Lung*/therapy
Lung Neoplasms*/pathology
Lung Neoplasms*/therapy
Humans ; Neoplasm Staging ; Retrospective Studies ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and F-FDG PET/CT for radiotherapy target volume definition.
Autorzy :
Guberina M; Department of Radiation Therapy, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany. .
Darwiche K; Department of Pulmonary Medicine, Section of Interventional Pneumology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Hautzel H; Department of Nuclear Medicine, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Pöttgen C; Department of Radiation Therapy, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Guberina N; Department of Radiation Therapy, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Gauler T; Department of Radiation Therapy, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Ploenes T; Department of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Umutlu L; Institute of Diagnostic, Interventional Radiology and Neuroradiology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Theegarten D; Institute of Pathology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Aigner C; Department of Thoracic Surgery and Thoracic Endoscopy, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Eberhardt WEE; Department of Medical Oncology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; Division of Thoracic Oncology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Metzenmacher M; Department of Medical Oncology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; Division of Thoracic Oncology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Wiesweg M; Department of Medical Oncology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; Division of Thoracic Oncology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Karpf-Wissel R; Department of Pulmonary Medicine, Section of Interventional Pneumology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Schuler M; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.; Department of Medical Oncology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; Division of Thoracic Oncology, University Medicine Essen - Ruhrlandklinik, West German Cancer Center, University Duisburg-Essen, Essen, Germany.
Herrmann K; Department of Nuclear Medicine, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Stuschke M; Department of Radiation Therapy, University Hospital Essen, West German Cancer Center, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
Pokaż więcej
Źródło :
Radiation oncology (London, England) [Radiat Oncol] 2021 Sep 15; Vol. 16 (1), pp. 176. Date of Electronic Publication: 2021 Sep 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Curcumol Inhibits Lung Adenocarcinoma Growth and Metastasis via Inactivation of PI3K/AKT and Wnt/-Catenin Pathway.
Autorzy :
Li S; Department of Chemotherapy, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Zhou G; Department of Chemotherapy, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Liu W; Department of Radiotherapy, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Ye J; Department of Radiotherapy, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Yuan F; Department of Thoracic Surgery, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Zhang Z; Department of Thoracic Surgery, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Nanjing Medical University Affiliated Cancer HospitalNanjingP.R. China.
Pokaż więcej
Źródło :
Oncology research [Oncol Res] 2021 Sep 07; Vol. 28 (7), pp. 685-700. Date of Electronic Publication: 2020 Jun 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prognostic Value of Computed Tomography and/or F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.
Autorzy :
Moran A; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, CA.
Wang Y; Department of Statistics, University of California Davis, Davis, CA.
Dyer BA; Department of Radiation Oncology, University of Washington School of Medicine, Seattle, WA.
Yip SSF; AIQ Solutions Inc, Madison, WI.
Daly ME; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, CA.
Yamamoto T; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, CA. Electronic address: .
Pokaż więcej
Źródło :
Clinical lung cancer [Clin Lung Cancer] 2021 Sep; Vol. 22 (5), pp. 461-468. Date of Electronic Publication: 2021 Mar 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Radiation Therapy Planning of Thoracic Tumors: A Review of Challenges Associated With Lung Toxicities and Potential Perspectives of Gallium-68 Lung PET/CT Imaging.
Autorzy :
Lucia F; Radiation Oncology Department, University Hospital, Brest, France.
Rehn M; Radiation Oncology Department, University Hospital, Brest, France.
Blanc-Béguin F; Service de médecine nucléaire, CHRU de Brest, EA3878 (GETBO), Université de Brest, Brest, France.
Le Roux PY; Service de médecine nucléaire, CHRU de Brest, EA3878 (GETBO), Université de Brest, Brest, France.
Pokaż więcej
Źródło :
Frontiers in medicine [Front Med (Lausanne)] 2021 Aug 27; Vol. 8, pp. 723748. Date of Electronic Publication: 2021 Aug 27 (Print Publication: 2021).
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Outcomes in 36 Patients with Stage IIIA-N2 Squamous Cell Carcinoma of the Lung Treated with Nab-Paclitaxel Plus Carboplatin as Neoadjuvant Therapy: A Prospective Study from a Single Center.
Autorzy :
Zhu J; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Zhang Y; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Wang M; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Zhang Z; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Yue D; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Liu S; Department of Radiology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Pan Y; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Wang C; Department of Lung Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Lung Cancer Center, Tianjin Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China (mainland).
Pokaż więcej
Źródło :
Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2021 Aug 11; Vol. 27, pp. e930738. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Durvalumab after Chemoradiotherapy for PD-L1 Expressing Inoperable Stage III NSCLC Leads to Significant Improvement of Local-Regional Control and Overall Survival in the Real-World Setting.
Autorzy :
Taugner, Julian (AUTHOR)
Käsmann, Lukas (AUTHOR)
Eze, Chukwuka (AUTHOR)
Tufman, Amanda (AUTHOR)
Reinmuth, Niels (AUTHOR)
Duell, Thomas (AUTHOR)
Belka, Claus (AUTHOR)
Manapov, Farkhad (AUTHOR)
Mukherjee, Sudip (AUTHOR)
Paul, Manash (AUTHOR)
Pokaż więcej
Źródło :
Cancers. Apr2021, Vol. 13 Issue 7, p1613-1613. 1p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies